Sosei initiates oropharyngeal candidiasis trial
Japan | News | By BioSpectrum Bureau | 0 Comment | 13 Mar, 2013
Singapore: Sosei Group's Japanese subsidiary initiated a phase III trial for SO-1105 for the treatment of oropharyngeal...Read more
Japan study: Sugar solution makes tissue transparent
Japan | News | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2013
Singapore: Researchers from Japan's RIKEN Center for Developmental biology have developed a new sugar and water-based so...Read more
Astellas, Cytokinetics sign $490 mn muscle deal
Japan | News | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2013
Singapore: US-based Cytokinetics and Japan-based Astellas Pharma entered in a two-year collaboration focused on the R&am...Read more
Astellas, XenoPort launch Regnite in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2012
Singapore: Astellas Pharma and XenoPort have launched Regnite (gabapentin enacarbil) extended-release tablets. Regnite i...Read more
TSRI, Takeda expand research collaboration
Japan | News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2013
Singapore: The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research collabo...Read more
Japanese I'rom acquires 18% in Australian IDT
Japan | News | By BioSpectrum Bureau | 0 Comment | 07 May, 2013
Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the T...Read more
Iressa deaths: Japanese High Court rules in favor of AZ
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 May, 2012
Singapore: The Japanese unit of AstraZeneca (AZ), has been acquitted, in a case that had held the firm responsible for t...Read more
Asia vaccine strategists call for collaboration
Japan | News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2013
Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply...Read more
Daiichi Sankyo, Ranbaxy to leverage synergies in Thailand
Japan | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand...Read more
RIKEN's new chip detects traces of miRNA in only 20 mins
Japan | News | By BioSpectrum Bureau | 0 Comment | 09 Nov, 2012
Singapore: A new power-free microfluidic chip developed by researchers at the RIKEN Advanced Science Institute, Japan, ...Read more
Hoya appoints new executive officer
Japan | News | By BioSpectrum Bureau | 0 Comment | 26 May, 2014
Singapore: Japan based Hoya Corporation has appointed Mr Augustine Yee as its executive officer, chief legal officer and...Read more
Takeda's center among Chicago's top 100 workplaces
Japan | News | By BioSpectrum Bureau | 0 Comment | 14 Nov, 2012
Singapore: Takeda Pharmaceuticals' Deerfield campus has been listed among Chicago's top 100 workplaces by the Chicago T...Read more
Eisai launches beauty drink in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 26 Feb, 2013
Singapore: Japan-based Eisai is going to launch its new carbonated supplement drink named 'Chocola BB Sparkling + Fiber'...Read more
Eisai seeks nod for Helicobacter Pylori treatment
Japan | News | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2012
Singapore: Eisai, which has its headquarters in Tokyo, has submitted a marketing authorization application to Japan's Mi...Read more
Will Keryx's ferric citrate NDA get nod in Japan?
Japan | News | By BioSpectrum Bureau | 0 Comment | 08 Jan, 2013
Singapore: Keryx Biopharmaceuticals announced that its Japanese partner, Japan Tobacco (JT), has filed a New Drug Appli...Read more
FDA accepts sNDA for Astellas cancer drug
Japan | Regulatory | By BioSpectrum Bureau | 0 Comment | 17 Jan, 2013
Singapore: The US FDA has accepted Astellas Pharma's US subsidiary filing of a supplemental New Drug Application (sNDA) ...Read more
EMA to review marketing plea for antipsychotic medication
Japan | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an aty...Read more
Ranbaxy advisory: All our products are safe and efficacious
Japan | News | By BioSpectrum Bureau | 0 Comment | 03 Jun, 2013
New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and eff...Read more